{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T07:43:27Z","timestamp":1648885407008},"reference-count":58,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2020.11555","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T10:21:49Z","timestamp":1587464509000},"source":"Crossref","is-referenced-by-count":0,"title":["STAT1 is a modulator of the expression of frequently rearranged in advanced T\u2011cell lymphomas\ufffd1 expression in U251 cells"],"prefix":"10.3892","author":[{"given":"Geng","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi 030000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shule","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi 030000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yining","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi 030000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeqing","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi 030000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqiang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi 030000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi 030000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi 030000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2020,4,21]]},"reference":[{"key":"key20200714151844_b1-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/jnen\/61.3.215","article-title":"The WHO classification of tumors of the nervous system","volume":"61","author":"Kleihues","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"key":"key20200714151844_b2-ol-0-0-11555","first-page":"244","article-title":"Classification and biology of astrocytic gliomas","volume":"8","author":"Schiffer","year":"1998","journal-title":"Forum (Genova)"},{"key":"key20200714151844_b3-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/glia.440150303","article-title":"Histopathology, classification, and grading of gliomas","volume":"15","author":"Kleihues","year":"1995","journal-title":"Glia"},{"key":"key20200714151844_b4-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s002920050098","article-title":"Revised WHO classification and new developments in diagnosis of central nervous system tumors","volume":"16","author":"Wiestler","year":"1995","journal-title":"Pathologe"},{"key":"key20200714151844_b5-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol"},{"key":"key20200714151844_b6-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/neuonc\/1.1.44","article-title":"Primary and secondary glioblastomas: From concept to clinical diagnosis","volume":"1","author":"Kleihues","year":"1999","journal-title":"Neuro Oncol"},{"key":"key20200714151844_b7-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0303-8467(97)80008-X","article-title":"Management of glioblastoma multiforme: With special reference to recurrence","volume":"99","author":"Durmaz","year":"1997","journal-title":"Clin Neurol Neurosurg"},{"key":"key20200714151844_b8-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1023\/A:1005909127196","article-title":"Bone marrow metastasis in astrocytic gliomata","volume":"37","author":"Hsu","year":"1998","journal-title":"J Neurooncol"},{"key":"key20200714151844_b9-ol-0-0-11555","first-page":"186","article-title":"A review of the treatment and survival rates of 138 patients with glioblastoma multiforme","volume":"92","author":"Jubelirer","year":"1996","journal-title":"W V Med J"},{"key":"key20200714151844_b10-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1093\/jnen\/59.12.1044","article-title":"Systemic metastasis in glioblastoma may represent the emergence of neoplastic subclones","volume":"59","author":"Park","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"key":"key20200714151844_b11-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1017\/S0317167100034016","article-title":"Long-term glioblastoma multiforme survivors: A population-based study","volume":"25","author":"Scott","year":"1998","journal-title":"Can J Neurol Sci"},{"key":"key20200714151844_b12-ol-0-0-11555","first-page":"6205","article-title":"Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma","volume":"62","author":"Burton","year":"2002","journal-title":"Cancer Res"},{"key":"key20200714151844_b13-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1093\/brain\/awm204","article-title":"Long-term survival with glioblastoma multiforme","volume":"130","author":"Krex","year":"2007","journal-title":"Brain"},{"key":"key20200714151844_b14-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11060-011-0793-0","article-title":"Recent advances in the molecular understanding of glioblastoma","volume":"108","author":"Bleeker","year":"2012","journal-title":"J Neurooncol"},{"key":"key20200714151844_b15-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol"},{"key":"key20200714151844_b16-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"key20200714151844_b17-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0378-1119(02)00594-2","article-title":"Characterization and tissue-specific expression of human GSK-3-binding proteins FRAT1 and FRAT2","volume":"291","author":"Freemantle","year":"2002","journal-title":"Gene"},{"key":"key20200714151844_b18-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0092-8674(00)81208-8","article-title":"GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis","volume":"93","author":"Yost","year":"1998","journal-title":"Cell"},{"key":"key20200714151844_b19-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"9961","DOI":"10.1007\/s13277-015-3752-0","article-title":"The clinical significance of FRAT1 and ABCG2 expression in pancreatic ductal adenocarcinoma","volume":"36","author":"Yuan","year":"2015","journal-title":"Tumour Biol"},{"key":"key20200714151844_b20-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0925-4773(99)00187-2","article-title":"In vivo analysis of Frat1 deficiency suggests compensatory activity of Frat3","volume":"88","author":"Jonkers","year":"1999","journal-title":"Mech Dev"},{"key":"key20200714151844_b21-ol-0-0-11555","first-page":"785","article-title":"Molecular cloning and expression of proto-oncogene FRAT1 in human cancer","volume":"20","author":"Saitoh","year":"2002","journal-title":"Int J Oncol"},{"key":"key20200714151844_b22-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/emboj\/16.3.441","article-title":"Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas","volume":"16","author":"Jonkers","year":"1997","journal-title":"EMBO J"},{"key":"key20200714151844_b23-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"5982","DOI":"10.1038\/sj.onc.1202995","article-title":"Overexpression of Frat1 in transgenic mice leads to glomerulosclerosis and nephrotic syndrome, and provides direct evidence for the involvement of Frat1 in lymphoma progression","volume":"18","author":"Jonkers","year":"1999","journal-title":"Oncogene"},{"key":"key20200714151844_b24-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/sj.bjc.6602988","article-title":"Tissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of beta-catenin in ovarian tumours","volume":"94","author":"Wang","year":"2006","journal-title":"Br J Cancer"},{"key":"key20200714151844_b25-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s13277-012-0394-3","article-title":"Expression of Frat1 correlates with expression of \u03b2-catenin and is associated with a poor clinical outcome in human SCC and AC","volume":"33","author":"Zhang","year":"2012","journal-title":"Tumour Biol"},{"key":"key20200714151844_b26-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00428-011-1135-5","article-title":"Overexpression of Frat1 correlates with malignant phenotype and advanced stage in human non-small cell lung cancer","volume":"459","author":"Zhang","year":"2011","journal-title":"Virchows Arch"},{"key":"key20200714151844_b27-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.3892\/or.2016.5130","article-title":"Knockdown of FRAT1 inhibits hypoxia-induced epithelial-to-mesenchymal transition via suppression of the Wnt\/\u03b2-catenin pathway in hepatocellular carcinoma cells","volume":"36","author":"Fan","year":"2016","journal-title":"Oncol Rep"},{"key":"key20200714151844_b28-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"e61206","DOI":"10.1371\/journal.pone.0061206","article-title":"Knockdown of FRAT1 expression by RNA interference inhibits human glioblastoma cell growth, migration and invasion","volume":"8","author":"Guo","year":"2013","journal-title":"PLoS One"},{"key":"key20200714151844_b29-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"70494","DOI":"10.18632\/oncotarget.12038","article-title":"COL3A1 and SNAP91: Novel glioblastoma markers with diagnostic and prognostic value","volume":"7","author":"Gao","year":"2016","journal-title":"Oncotarget"},{"key":"key20200714151844_b30-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"e29653","DOI":"10.1371\/journal.pone.0029653","article-title":"Expression signature of IFN\/STAT1 signaling genes predicts poor survival outcome in glioblastoma multiforme in a subtype-specific manner","volume":"7","author":"Duarte","year":"2012","journal-title":"PLoS One"},{"key":"key20200714151844_b31-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/1471-2229-14-169","article-title":"RNA-seq analyses of multiple meristems of soybean: Novel and alternative transcripts, evolutionary and functional implications","volume":"14","author":"Wang","year":"2014","journal-title":"BMC Plant Biol"},{"key":"key20200714151844_b32-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: A software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"key20200714151844_b33-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"W720","DOI":"10.1093\/nar\/gkl167","article-title":"KOBAS server: A web-based platform for automated annotation and pathway identification","volume":"34","author":"Wu","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"key20200714151844_b34-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1186\/1471-2105-8-426","article-title":"DAVID Knowledgebase: A gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis","volume":"8","author":"Sherman","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"key20200714151844_b35-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in ingenuity pathway analysis","volume":"30","author":"Kramer","year":"2014","journal-title":"Bioinformatics"},{"key":"key20200714151844_b36-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/S0014-5793(01)02990-8","article-title":"GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and beta-catenin stabilisation without elevation of glycogen synthase activity","volume":"507","author":"Culbert","year":"2001","journal-title":"FEBS Lett"},{"key":"key20200714151844_b37-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"35021","DOI":"10.1074\/jbc.M607003200","article-title":"FRAT1, a substrate-specific regulator of glycogen synthase kinase-3 activity, is a cellular substrate of protein kinase A","volume":"281","author":"Hagen","year":"2006","journal-title":"J Biol Chem"},{"key":"key20200714151844_b38-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1093\/emboj\/18.15.4233","article-title":"Axin and Frat1 interact with Dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1","volume":"18","author":"Li","year":"1999","journal-title":"EMBO J"},{"key":"key20200714151844_b39-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0014-5793(99)01161-8","article-title":"A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and beta-catenin","volume":"458","author":"Thomas","year":"1999","journal-title":"FEBS Lett"},{"key":"key20200714151844_b40-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.biocel.2012.03.001","article-title":"Wnt signaling from membrane to nucleus: \u03b2-catenin caught in a loop","volume":"44","author":"Jamieson","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"key":"key20200714151844_b41-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00428-011-1135-5","article-title":"Overexpression of Frat1 correlates with malignant phenotype and advanced stage in human non-small cell lung cancer","volume":"459","author":"Yong","year":"2011","journal-title":"Virchows Archiv"},{"key":"key20200714151844_b42-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-009-9402-x","article-title":"FRAT1 expression and its correlation with pathologic grade, proliferation, and apoptosis in human astrocytomas","volume":"28","author":"Guo","year":"2011","journal-title":"Med Oncol"},{"key":"key20200714151844_b43-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0092-8674(00)81277-5","article-title":"STATs: Signal transducers and activators of transcription","volume":"84","author":"Ihle","year":"1996","journal-title":"Cell"},{"key":"key20200714151844_b44-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1038\/sj.onc.1203527","article-title":"STATs in oncogenesis","volume":"19","author":"Bowman","year":"2000","journal-title":"Oncogene"},{"key":"key20200714151844_b45-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1182\/blood.V93.6.1980.406k20_1980_1991","article-title":"Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells","volume":"93","author":"Matikainen","year":"1999","journal-title":"Blood"},{"key":"key20200714151844_b46-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0092-8674(00)81959-5","article-title":"Stat3 as an oncogene","volume":"98","author":"Bromberg","year":"1999","journal-title":"Cell"},{"key":"key20200714151844_b47-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"6519","DOI":"10.1158\/0008-5472.CAN-14-0847","article-title":"STAT1 drives tumor progression in serous papillary endometrial cancer","volume":"74","author":"Kharma","year":"2014","journal-title":"Cancer Res"},{"key":"key20200714151844_b48-ol-0-0-11555","first-page":"5348","article-title":"Enforced expression of the Mr 33,000 Pim-1 kinase enhances factor-independent survival and inhibits apoptosis in murine myeloid cells","volume":"57","author":"Lilly","year":"1997","journal-title":"Cancer Res"},{"key":"key20200714151844_b49-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"10734","DOI":"10.1073\/pnas.90.22.10734","article-title":"Expression of a Pim-1 transgene accelerates lymphoproliferation and inhibits apoptosis in lpr\/lpr mice","volume":"90","author":"Moroy","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200714151844_b50-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.18632\/oncotarget.3208","article-title":"High expression of N-myc (and STAT) interactor predicts poor prognosis and promotes tumor growth in human glioblastoma","volume":"6","author":"Meng","year":"2015","journal-title":"Oncotarget"},{"key":"key20200714151844_b51-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1182\/blood.V87.5.1692.1692","article-title":"STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients","volume":"87","author":"Gouilleux-Gruart","year":"1996","journal-title":"Blood"},{"key":"key20200714151844_b52-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1172\/JCI3785","article-title":"Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth In vitro","volume":"102","author":"Grandis","year":"1998","journal-title":"J Clin Invest"},{"key":"key20200714151844_b53-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3109\/10428199709058334","article-title":"Activated Stat related transcription factors in acute leukemia","volume":"28","author":"Gouilleux-Gruart","year":"1997","journal-title":"Leuk Lymphoma"},{"key":"key20200714151844_b54-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0","article-title":"Activation of STAT proteins and growth control","volume":"23","author":"Bromberg","year":"2001","journal-title":"Bioessays"},{"key":"key20200714151844_b55-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/00001622-199911000-00010","article-title":"STAT proteins as novel targets for cancer therapy. Signal transducer an activator of transcription","volume":"11","author":"Catlett-Falcone","year":"1999","journal-title":"Curr Opin Oncol"},{"key":"key20200714151844_b56-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1126\/science.8197455","article-title":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins","volume":"264","author":"Darnell","year":"1994","journal-title":"Science"},{"key":"key20200714151844_b57-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S1074-7613(00)00039-X","article-title":"Abnormal Stat activation, hematopoietic homeostasis, and innate immunity in c-fes-\/- mice","volume":"13","author":"Hackenmiller","year":"2000","journal-title":"Immunity"},{"key":"key20200714151844_b58-ol-0-0-11555","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1158\/0008-5472.CAN-17-0599","article-title":"Oncolytic virotherapy blockade by microglia and macrophages requires STAT1\/3","volume":"78","author":"Delwar","year":"2018","journal-title":"Cancer Res"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T14:35:00Z","timestamp":1594737300000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2020.11555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,21]]},"references-count":58,"URL":"https:\/\/doi.org\/10.3892\/ol.2020.11555","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,21]]}}}